Fundación Jiménez Díaz University Hospital Trials

Fundación Jiménez Díaz University Hospital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ibanez, Borja

NCT03596385 / 2017-002485-40: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

8507

Europe

Beta blocker, atenolol, bisoprolol, carvedilol, metoprolol, nevibolol.

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Myocardial Infarction

01/25

MAIDEN, NCT05847517: Metoprolol in Acute Respiratory Distress Syndrome

Recruiting

350

Europe

Metoprolol Injection, saline 0.9%

Consorcio Centro de Investigación Biomédica en Red (CIBER), European Commission, Instituto de Salud Carlos III

Acute Respiratory Distress Syndrome (ARDS)

09/25

12/27

DETECT, NCT06692127: ion of the Prevalence of Silent Atherosclerosis Across Adult Life

Recruiting

N/A

16000

Europe

Rigshospitalet, Denmark, The Novo Nordic Foundation, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Gødstrup Hospital, Herlev and Gentofte Hospital

Atheroslerosis

12/26

07/32

MuÃ±oz, Luis A

AMERICCAASS, NCT05295641: American Registry of Ambulatory or Acutely Decompensated Heart Failure

Completed

N/A

6732

US, RoW

Fundacion Clinica Valle del Lili, Sociedad Interamericana de Cardiología (SIAC), Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)

Heart Failure, Acute Heart Failure (AHF), Chronic Heart Failure

01/25

RELAP, NCT05363813: Post-market Clinical Follow-up Study of Reusable Clip Applier Cartridge Devices for LAParoscopic Surgery

Active, not recruiting

N/A

230

Europe

M/L-10 Multi-Fire Clip Applier and M/L-10 Clip Cartridge (Multi-Fire Clip System)

Microline Surgical, Inc., AKRN Scientific Consulting, S.L.

Minimally Invasive Surgical Procedures, Laparoscopy, Leakage of Cardiac Device

09/24

11/24

Rubio, Jose Manuel

NCT06716606: A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Recruiting

225

RoW

Belimumab

GlaxoSmithKline, ICON plc

Bronchial Diseases

07/28

01/30

TOPAZ-1, NCT04895241 / 2020-005775-12: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

	Trial initiation of TOPAZ-1 trial in lupus
	Jun 2021 - Jun 2021: Trial initiation of TOPAZ-1 trial in lupus

Recruiting

540

Europe, US, RoW

Litifilimab, BIIB059, Placebo

Biogen

Lupus Erythematosus, Systemic

09/26

03/27

OCEAN, NCT05263934 / 2021-005726-15: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Recruiting

160

Europe, Canada, Japan, US, RoW

Depemokimab, Mepolizumab, Placebo matching mepolizumab, Placebo matching depemokimab

GlaxoSmithKline

Eosinophilic Granulomatosis With Polyangiitis

05/26

06/26

SIRIUS-LN, NCT05126277 / 2020-005830-14: Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Recruiting

420

Europe, Canada, US, RoW

ianalumab s.c. q4w, VAY736, ianalumab s.c. q12w, placebo s.c., placebo

Novartis Pharmaceuticals, Novartis Pharma AG

Lupus Nephritis

03/27

07/30

BLISSc-ILD, NCT05878717: A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Jan 2021 - Jun 2021 : Submission in combination with rituximab for SLE

Recruiting

2/3

300

Europe, Japan, US, RoW

Belimumab, BENLYSTA™, GSK1550188, LymphoStat-B™, BENLYSTATM, GSK1550188, LymphoStat-B™, Placebo

GlaxoSmithKline

Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic

05/27

07/27

NCT05798117: An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Active, not recruiting

1/2

Europe, US, RoW

YTB323

Novartis Pharmaceuticals

Systemic Lupus Erythematosus, Lupus Nephritis

09/26

EFINUTRILES, NCT05261529: Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus

Recruiting

N/A

Europe

Extra Virgin Olive Oil (EVOO), Physical Exercise Program

Universidad de Granada, Consejería de Economía, Innovación y Ciencia. Proyectos de I+D+I en el marco operativo Feder Andalucía 2014-2020

Lupus Erythematosus, Systemic

12/22

06/23

NCT06101472: Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens.

Recruiting

N/A

Europe

ASQELIO Toric Biaspheric Monofocal Lens

AST Products, Inc.

Cataract

08/24

10/24

STYLE-LBBP, NCT06049992: STylet-driven vs. LumenlEss Lead in Left-Bundle-Branch Pacing

Recruiting

N/A

120

Europe

Pacemaker implantation with conduction system pacing using Lumenless leads, Pacemaker implantation with conduction system pacing using Stylet-driven leads

Puerta de Hierro University Hospital, Spanish Society of Cardiology

Left Bundle-Branch Pacing

09/25

Gomez-Talavera, Sandra

NCT03596385 / 2017-002485-40: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

8507

Europe

Beta blocker, atenolol, bisoprolol, carvedilol, metoprolol, nevibolol.

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Myocardial Infarction

01/25

Fernandez, Felipe

NCT03596385 / 2017-002485-40: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

8507

Europe

Beta blocker, atenolol, bisoprolol, carvedilol, metoprolol, nevibolol.

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Myocardial Infarction

01/25

Rojo, Federico

PLANET, NCT05167487: Pathological Response After Neoadjuvant Treatment on NSCLC

Recruiting

N/A

150

Europe

Cisplatin, Cis-diammine-dichloroplatinum, Platinol, Carboplatin, Paraplatin

Fundación GECP

Stage IIIA Non-small Cell Lung Cancer

04/25

12/25

NCT04772833: Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Recruiting

N/A

Europe

Autopsy

MaimÃ³nides Biomedical Research Institute of CÃ³rdoba, Spanish Society of Infectious Diseases and Clinical Microbiology, Spanish Society of Pathological Anatomy

Covid19

12/21

Prieto, Laura

NCT04772833: Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Recruiting

N/A

Europe

Autopsy

MaimÃ³nides Biomedical Research Institute of CÃ³rdoba, Spanish Society of Infectious Diseases and Clinical Microbiology, Spanish Society of Pathological Anatomy

Covid19

12/21

Santos-Oviedo, Arnoldo

MAIDEN, NCT05847517: Metoprolol in Acute Respiratory Distress Syndrome

Recruiting

350

Europe

Metoprolol Injection, saline 0.9%

Consorcio Centro de Investigación Biomédica en Red (CIBER), European Commission, Instituto de Salud Carlos III

Acute Respiratory Distress Syndrome (ARDS)

09/25

12/27

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ibanez, Borja

NCT03596385 / 2017-002485-40: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

8507

Europe

Beta blocker, atenolol, bisoprolol, carvedilol, metoprolol, nevibolol.

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Myocardial Infarction

01/25

MAIDEN, NCT05847517: Metoprolol in Acute Respiratory Distress Syndrome

Recruiting

350

Europe

Metoprolol Injection, saline 0.9%

Consorcio Centro de Investigación Biomédica en Red (CIBER), European Commission, Instituto de Salud Carlos III

Acute Respiratory Distress Syndrome (ARDS)

09/25

12/27

DETECT, NCT06692127: ion of the Prevalence of Silent Atherosclerosis Across Adult Life

Recruiting

N/A

16000

Europe

Rigshospitalet, Denmark, The Novo Nordic Foundation, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Gødstrup Hospital, Herlev and Gentofte Hospital

Atheroslerosis

12/26

07/32

MuÃ±oz, Luis A

AMERICCAASS, NCT05295641: American Registry of Ambulatory or Acutely Decompensated Heart Failure

Completed

N/A

6732

US, RoW

Fundacion Clinica Valle del Lili, Sociedad Interamericana de Cardiología (SIAC), Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)

Heart Failure, Acute Heart Failure (AHF), Chronic Heart Failure

01/25

RELAP, NCT05363813: Post-market Clinical Follow-up Study of Reusable Clip Applier Cartridge Devices for LAParoscopic Surgery

Active, not recruiting

N/A

230

Europe

M/L-10 Multi-Fire Clip Applier and M/L-10 Clip Cartridge (Multi-Fire Clip System)

Microline Surgical, Inc., AKRN Scientific Consulting, S.L.

Minimally Invasive Surgical Procedures, Laparoscopy, Leakage of Cardiac Device

09/24

11/24

Rubio, Jose Manuel

NCT06716606: A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Recruiting

225

RoW

Belimumab

GlaxoSmithKline, ICON plc

Bronchial Diseases

07/28

01/30

	Trial initiation of TOPAZ-1 trial in lupus
	Jun 2021 - Jun 2021: Trial initiation of TOPAZ-1 trial in lupus

Recruiting

540

Europe, US, RoW

Litifilimab, BIIB059, Placebo

Biogen

Lupus Erythematosus, Systemic

09/26

03/27

OCEAN, NCT05263934 / 2021-005726-15: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Recruiting

160

Europe, Canada, Japan, US, RoW

Depemokimab, Mepolizumab, Placebo matching mepolizumab, Placebo matching depemokimab

GlaxoSmithKline

Eosinophilic Granulomatosis With Polyangiitis

05/26

06/26

SIRIUS-LN, NCT05126277 / 2020-005830-14: Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Recruiting

420

Europe, Canada, US, RoW

ianalumab s.c. q4w, VAY736, ianalumab s.c. q12w, placebo s.c., placebo

Novartis Pharmaceuticals, Novartis Pharma AG

Lupus Nephritis

03/27

07/30

BLISSc-ILD, NCT05878717: A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Jan 2021 - Jun 2021 : Submission in combination with rituximab for SLE

Recruiting

2/3

300

Europe, Japan, US, RoW

Belimumab, BENLYSTA™, GSK1550188, LymphoStat-B™, BENLYSTATM, GSK1550188, LymphoStat-B™, Placebo

GlaxoSmithKline

Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic

05/27

07/27

NCT05798117: An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Active, not recruiting

1/2

Europe, US, RoW

YTB323

Novartis Pharmaceuticals

Systemic Lupus Erythematosus, Lupus Nephritis

09/26

EFINUTRILES, NCT05261529: Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus

Recruiting

N/A

Europe

Extra Virgin Olive Oil (EVOO), Physical Exercise Program

Universidad de Granada, Consejería de Economía, Innovación y Ciencia. Proyectos de I+D+I en el marco operativo Feder Andalucía 2014-2020

Lupus Erythematosus, Systemic

12/22

06/23

NCT06101472: Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens.

Recruiting

N/A

Europe

ASQELIO Toric Biaspheric Monofocal Lens

AST Products, Inc.

Cataract

08/24

10/24

STYLE-LBBP, NCT06049992: STylet-driven vs. LumenlEss Lead in Left-Bundle-Branch Pacing

Recruiting

N/A

120

Europe

Pacemaker implantation with conduction system pacing using Lumenless leads, Pacemaker implantation with conduction system pacing using Stylet-driven leads

Puerta de Hierro University Hospital, Spanish Society of Cardiology

Left Bundle-Branch Pacing

09/25

Gomez-Talavera, Sandra

NCT03596385 / 2017-002485-40: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

8507

Europe

Beta blocker, atenolol, bisoprolol, carvedilol, metoprolol, nevibolol.

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Myocardial Infarction

01/25

Fernandez, Felipe

NCT03596385 / 2017-002485-40: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

8507

Europe

Beta blocker, atenolol, bisoprolol, carvedilol, metoprolol, nevibolol.

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Myocardial Infarction

01/25

Rojo, Federico

PLANET, NCT05167487: Pathological Response After Neoadjuvant Treatment on NSCLC

Recruiting

N/A

150

Europe

Cisplatin, Cis-diammine-dichloroplatinum, Platinol, Carboplatin, Paraplatin

Fundación GECP

Stage IIIA Non-small Cell Lung Cancer

04/25

12/25

NCT04772833: Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Recruiting

N/A

Europe

Autopsy

MaimÃ³nides Biomedical Research Institute of CÃ³rdoba, Spanish Society of Infectious Diseases and Clinical Microbiology, Spanish Society of Pathological Anatomy

Covid19

12/21

Prieto, Laura

NCT04772833: Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Recruiting

N/A

Europe

Autopsy

MaimÃ³nides Biomedical Research Institute of CÃ³rdoba, Spanish Society of Infectious Diseases and Clinical Microbiology, Spanish Society of Pathological Anatomy

Covid19

12/21

Santos-Oviedo, Arnoldo

MAIDEN, NCT05847517: Metoprolol in Acute Respiratory Distress Syndrome

Recruiting

350

Europe

Metoprolol Injection, saline 0.9%

Consorcio Centro de Investigación Biomédica en Red (CIBER), European Commission, Instituto de Salud Carlos III

Acute Respiratory Distress Syndrome (ARDS)

09/25

12/27



	Diseases Companies Products Productz Mechanisms of Action Sites